Deutsch English Français

Contact

EP0939810

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0939810

EP0939810 - TRANSCRIPTIONAL INTERMEDIARY FACTOR-2 TIF2 [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 14.12.2007 Database last updated on 14.09.2024
Most recent event Tooltip	08.08.2008	Change - applicant	published on 10.09.2008 [2008/37]
Applicant(s)	For all designated states INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 101, rue de Tolbiac 75654 Paris Cédex 13 / FR
	For all designated states Centre National de la Recherche Scientifique 3, rue Michel-Ange 75016 Paris / FR
	For all designated states UNIVERSITE LOUIS PASTEUR 4, rue Blaise Pascal, Boite postale 1032F 67070 Strasbourg Cedex / FR
	For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US
	[N/P]
Former [2008/37]	For all designated states INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 101, rue de Tolbiac 75654 Paris Cédex 13 / FR
	For all designated states CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 3, rue Michel Ange 75016 Paris Cédex / FR
	For all designated states UNIVERSITE LOUIS PASTEUR 4, rue Blaise Pascal, Boite postale 1032F 67070 Strasbourg Cedex / FR
	For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton NJ 05843-4000 / US
Former [2007/06]	For all designated states INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 101, rue de Tolbiac 75654 Paris Cédex 13 / FR
	For all designated states CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 3, rue Michel Ange 75016 Paris Cédex / FR
	For all designated states UNIVERSITE LOUIS PASTEUR 4, rue Blaise Pascal, Boite postale 1032F 67070 Strasbourg Cedex / FR
	For all designated states Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ 08543-4000 / US
Former [1999/36]	For all designated states INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 101, rue de Tolbiac 75654 Paris Cédex 13 / FR
	For all designated states CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 3 rue Michel Ange 75794 Paris Cédex 16 / FR
	For all designated states Universite Louis Pasteur 4, rue Blaise Pascal, Boite postale 1032F 67070 Strasbourg Cedex / FR
	For all designated states Bristol-Myers Squibb Company Route 206 & Provinceline Road Princeton, NJ 08543-4000 / US
Inventor(s)	01 / CHAMBON, Pierre 4, rue A. Schweitzer F-67113 Blaesheim / FR
	02 / GRONEMEYER, Hinrich Uhlandstrasse 1A D-77704 Oberkirch / DE
	03 / VOEGEL, Johannes 2, rue du Cheval F-67100 Strasbourg / FR
	04 / LUTZ, Yves 12, rue d'Ypres F-67000 Strasbourg / FR
	[1999/36]
Representative(s)	Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE
	[N/P]
Former [1999/36]	VOSSIUS & PARTNER Postfach 86 07 67 81634 München / DE
Application number, filing date	97932575.0	11.07.1997
	[1999/36]
	WO1997US12100
Priority number, date	US19960021247P	12.07.1996 Original published format: US 21247 P
	[1999/36]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO9802455
	Date:	22.01.1998
	Language:	EN
	[1998/03]
	Type:	A2 Application without search report
	No.:	EP0939810
	Date:	08.09.1999
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 22.01.1998 takes the place of the publication of the European patent application.
	[1999/36]
	Type:	B1 Patent specification
	No.:	EP0939810
	Date:	07.02.2007
	Language:	EN
	[2007/06]
Search report(s)	International search report - published on:	EP	08.04.1999
Classification	IPC:	C12N15/12, C07K14/47, C07K16/18, G01N33/566, G01N33/50	[1999/36]
	CPC:	C07K14/4702 (EP,US)
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1999/36]
Title	German:	TRANSKRIPTIONS ZWISCHEN FAKTOR-2 TIF2	[1999/36]
	English:	TRANSCRIPTIONAL INTERMEDIARY FACTOR-2 TIF2	[1999/36]
	French:	FACTEUR-2 INTERMEDIAIRE DE LA TRANSCRIPTION	[1999/36]
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	12.02.1999	National basic fee paid
	12.02.1999	Designation fee(s) paid
	12.02.1999	Examination fee paid
Examination procedure	12.02.1998	Request for preliminary examination filed International Preliminary Examining Authority: EP
	12.02.1999	Examination requested [1999/36]
	12.03.2004	Despatch of a communication from the examining division (Time limit: M06)
	20.09.2004	Reply to a communication from the examining division
	10.12.2004	Despatch of a communication from the examining division (Time limit: M04)
	18.04.2005	Reply to a communication from the examining division
	15.06.2005	Despatch of a communication from the examining division (Time limit: M01)
	22.07.2005	Reply to a communication from the examining division
	08.05.2006	Communication of intention to grant the patent
	18.09.2006	Fee for grant paid
	18.09.2006	Fee for publishing/printing paid
Divisional application(s)	EP07101726.3 / EP1865060
Opposition(s)	08.11.2007	No opposition filed within time limit [2008/03]
Fees paid	Renewal fee
	09.07.1999	Renewal fee patent year 03
	10.07.2000	Renewal fee patent year 04
	05.07.2001	Renewal fee patent year 05
	04.07.2002	Renewal fee patent year 06
	04.07.2003	Renewal fee patent year 07
	09.07.2004	Renewal fee patent year 08
	08.07.2005	Renewal fee patent year 09
	12.07.2006	Renewal fee patent year 10
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	FI	07.02.2007
	NL	07.02.2007
	GR	08.05.2007
	PT	09.07.2007
	[2008/21]
Former [2008/08]	FI	07.02.2007
	NL	07.02.2007
	PT	09.07.2007
Cited in	International search	[XD] - J.J. VOEGEL ET AL., "TIF2, a 160kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors", THE EMBO JOURNAL, (1996), vol. 15, no. 14, pages 3667 - 3675, XP002045757 [XD] 1-20 * the whole document *
		[AD] - S.A. OÑATE ET AL., "Sequence and characterization of a coactivator for the Steroid Hormone Receptor Superfamily", SCIENCE, (19951124), vol. 270, pages 1354 - 1357, XP002045755 [AD] * the whole document *
		[A] - H. HONG ET AL., "GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors.", PROC. NATL. ACAD. SCI. USA, (199605), vol. 93, pages 4948 - 4952, XP002045756 [A] * the whole document * DOI: http://dx.doi.org/10.1073/pnas.93.10.4948
		[PXD] - H. HONG ET AL., "GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors", MOLECULAR AND CELLULAR BIOLOGY, (199705), vol. 17, no. 5, pages 2735 - 2744, XP002045758 [PXD] 1-20 * the whole document *
		[PXD] - C.K. GLASS ET AL., "Nuclear receptor coactivators", CURRENT OPINION IN CELL BIOLOGY, (199704), vol. 9, no. 2, pages 222 - 232, XP002045759 [PXD] 1-20 * table 2 * DOI: http://dx.doi.org/10.1016/S0955-0674(97)80066-X

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p